Skip to main content

Anaphylactoid reactions to radiocontrast media

Buy Article:

$31.50 plus tax (Refund Policy)

As the role for diagnostic and therapeutic contrast-enhanced imaging increases, review of the epidemiology, mechanisms, risk factors, and pretreatment for radiocontrast-mediated anaphylactoid reactions becomes more and more pertinent. Ongoing research has failed to elucidate the precise mechanisms of both early and late reactions, though the current data point to a multifactorial pathogenesis. The risk of reactions has decreased over time as contrast media have evolved from ionic, high-osmolality to nonionic, low-osmolality formulations; however, the expense of the low-osmolality agents limit their universal use. Today, 1–12% of patients exhibit adverse responses ranging from mild to severe, with individual risk depending on the type of contrast administered and certain baseline patient characteristics. For those high-risk patients who must receive contrast, effective pretreatment guidelines have been established.
No Reference information available - sign in for access.
No Citation information available - sign in for access.
No Supplementary Data.
No Article Media
No Metrics

Document Type: Review Article

Publication date: 2005-05-01

More about this publication?
  • Allergy and Asthma Proceedings is a peer reviewed publication dedicated to distributing timely scientific research regarding advancements in the knowledge and practice of allergy, asthma and immunology. Its primary readership consists of allergists and pulmonologists.

    The goal of the Proceedings is to publish articles with a predominantly clinical focus which directly impact quality of care for patients with allergic disease and asthma.

    Featured topics include asthma, rhinitis, sinusitis, food allergies, allergic skin diseases, diagnostic techniques, allergens, and treatment modalities. Published material includes peer-reviewed original research, clinical trials and review articles.

    Articles marked "F" offer free full text for personal noncommercial use only.

    The journal is indexed in Thomson Reuters Web of Science and Science Citation Index Expanded, plus the National Library of Medicine's PubMed service.
  • Editorial Board
  • Information for Authors
  • Submit a Paper
  • Information for Advertisers
  • Reprint Requests
  • www.AJRA.com
  • www.AllergyandRhinology.com
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more